Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Podar

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|January 11, 2005
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical applicationToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
Blood|October 24, 2002
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Teru Hideshima, Constantine Mitsiades, Masaharu Akiyama, et al.
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
Blood|January 19, 2006
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Hiroshi Yasui, et al.
Cancer Research|September 17, 2005
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Blood|October 16, 2004
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen speciesJeong H Kim, Stephanie C Chu, Jessica L Gramlich, et al.
Breast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.
Blood|September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivoBoris Lin, Laurence Catley, Richard LeBlanc, et al.
Cancers|September 10, 2021
Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic PatientsJosef Singer, Nguyen-Son Le, Daniel Mattes, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|January 11, 2005
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical applicationToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
Blood|October 24, 2002
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Teru Hideshima, Constantine Mitsiades, Masaharu Akiyama, et al.
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
Blood|January 19, 2006
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Hiroshi Yasui, et al.
Cancer Research|September 17, 2005
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Blood|October 16, 2004
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen speciesJeong H Kim, Stephanie C Chu, Jessica L Gramlich, et al.
Breast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.
Blood|September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivoBoris Lin, Laurence Catley, Richard LeBlanc, et al.
Cancers|September 10, 2021
Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic PatientsJosef Singer, Nguyen-Son Le, Daniel Mattes, et al.
Pageof 15